Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec in patients with type 2 diabetes: A randomized, open‐label, cross‐over study using continuous glucose monitoring profiles

AIMS/INTRODUCTION: Compared with glargine 100 U/mL (Gla100), glargine 300 U/mL (Gla300) and degludec (Deg) – the ultralong‐acting insulins – reportedly have more stable effects and reduce the risk of hypoglycemia. Currently, they are considered to be the most useful basal insulins. The present study...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Yuji, Sawa, Jun, Sakuma, Noriko, Kumeda, Yasuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400202/
https://www.ncbi.nlm.nih.gov/pubmed/29947060
http://dx.doi.org/10.1111/jdi.12884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400202/
https://www.ncbi.nlm.nih.gov/pubmed/29947060
http://dx.doi.org/10.1111/jdi.12884

Ejemplares similares